We are live on
!
Find out more
AstraZeneca
AZN
AZN
530 hedge funds and large institutions have $14B invested in AstraZeneca in 2018 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 145 increasing their positions, 197 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
187% more call options, than puts
Call options by funds: $164M | Put options by funds: $57.1M
40% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 43
2% more funds holding
Funds holding: 518 → 530 (+12)
1% more capital invested
Capital invested by funds: $13.9B → $14B (+$140M)
0.41% more ownership
Funds ownership: 15.68% → 16.09% (+0.41%)
26% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 197
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
530
Holders Change
+12
Holders Change %
+2.32%
% of All Funds
12.13%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
60
Increased
145
Reduced
197
Closed
43
Calls
$164M
Puts
$57.1M
Net Calls
+$107M
Net Calls Change
+$53.4M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$693M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$190M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$78.3M |
| 4 |
Primecap Management
Pasadena,
California
|
+$52.9M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$52.2M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$345M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$69.1M |
| 3 |
Dodge & Cox
San Francisco,
California
|
-$63.1M |
| 4 |
Goldman Sachs
New York
|
-$57.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$53.8M |
